In vitro assays
Our in vitro assays drive drug discovery from target identification to preclinical model selection, bridging the gap between lab testing and in vivo evaluation. We’re dedicated to selecting the best lead compounds and advancing them through optimal preclinical protocols.
At Oncodesign Services, we’re pioneers in scientific innovation, enhancing drug discovery through cutting-edge in vitro assays. We understand that high-quality in vitro data is vital for informed decisions throughout the drug development process.
Located across our two facilities in Dijon and Paris, our in vitro department comprises a team of 35 professionals, including 12 PhDs. Our state-of-the-art laboratories are equipped to handle BSL2 and BSL3 work, providing a range of comprehensive tests, including:
Biochemical and cell based functional assays (including the use of radioisotopes)
Metabolic – proliferation assays
Mechanistic assays: apoptosis, cell cycle, migration, invasion…
In vitro department offers more than 300 cell lines covering 90% of human cancers as well as PDX derived sample (organoid).
Our in vitro platform offers :